Hints and tips:
Related Special Reports
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...The pharmaceutical company had poured hundreds of millions of dollars into research and development for vaccines — and yet, at 33 years old, was approaching middle age without a single approved shot....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...seen on MTV — the 24-hour-a-day television network playing music videos — he formed SM Entertainment and set about replicating the success of the highly-trained all-singing, all-dancing groups like The Jackson...
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...The trigger for the bankruptcy process came last month when its subsidiary, Intelsat Jackson Holdings, failed to make a $135m interest payment. But trouble had been brewing months earlier....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...Mark Jackson, a portfolio manager at Diamond Hill Capital Management, said the demand showed investors were “starved” of yield....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...the neuroscience business should not “shock investors but is likely to raise a debate over possible use of proceeds should any cash be generated and management of any earnings dilution [ie deleveraging v...
...Why is it that more competition in the pharmaceutical industry drives prices up rather than down? Interview with Elizabeth Rosenthal of Kaiser Health News....
...Teva Pharmaceuticals is selling a €4bn bond today to fund its $41bn (€37bn) purchase of generic drugmaker Allergan....
...Teva Pharmaceuticals has tapped European bond investors for €4bn in a bond sale that will help fund its acquisition of the generics drugs unit of rival Allergan and underlines the appeal of a market buoyed...
...Ms Mhango is most upbeat of all, though, echoing Mr Jackson’s thoughts about the dispersion of knowledge....
...To take a recent example, ticket sales for Batman v Superman: Dawn of Justice dropped by an astonishing 68.4 per cent on its second weekend, as comic-book fans returned to their dens....
...These include Amgen, the pharmaceuticals company, US aerospace manufacturer United Technologies and LyondellBasell Industries — a US-listed chemicals company with European roots....
...Citigroup, Deutsche Bank and Morgan Stanley were the global co-ordinators, writes Gavin Jackson....
...faced with sudden paper losses as bond prices fell rapidly and pushed up yields, have become more risk averse as debt across at least half a dozen subsectors — including energy, materials, retail, media, pharmaceuticals...
...The Jackson, Mississippi-based company reported profits of $143m, or $2.95 a share, compared with $27.7m or 57 cents a share in the year-ago period....
International Edition